The cybersecurity technology producer was valued at $8.3bn in a round that included existing backers Liberty Global Ventures and Snowflake Ventures.

Cancer research software provider Owkin received the funding as part of a strategic collaboration partnership which will involve it working with Sanofi on potential treatments.

Subsidiaries of Alphabet and Cisco were among the investors which pushed the cybersecurity technology provider to unicorn status.

Schlumberger New Energy co-led a round for the water treatment specialist sized at over $100m, hiking its overall funding to more than $200m.

Labcorp backed a debt and equity round for the cancer diagnostics technology developer as it advances its screening platform torwards commercialisation.

Amir Kabir has departed from Munich Re Ventures to lead financial and insurance technology investments at the Allianz-backed AV8 Ventures.

Koch Disruptive Technologies helped molecular diagnostics system developer Sense Biodetection expand its latest round to $65m while Hilti bought portfolio company Fieldwire for $300m.

Q&A with Anand Kamannavar, global head, Applied Ventures

Citi Ventures-backed Braze priced the offering above its range and it valued the customer engagement software producer at almost $5.9bn.

Animoca Brands, Coinbase and HSBC were among the investors in a round valuing the blockchain software provider at $3.2bn.